(Press-News.org) Lactating mothers who get the COVID-19 booster pass along the antibodies to their children via their breast milk – and potentially protect babies too young to receive the vaccine, a study from the University of Florida Institute of Food and Agricultural Sciences (UF/IFAS) and the UF College of Medicine found.
The study is the third in a series that looks at antibody protection being transferred via breast milk from mothers who received their first two COVID-19 vaccinations and, now, the booster shot. The second publication reported the same antibody transfer via breast milk.
“We think that breast milk may play an important role in protecting the infants during the first six months of life from COVID,” said Dr. Vivian Valcarce, a former UF College of Medicine researcher who worked on this study. She now is an assistant professor at the University of Alabama at Birmingham. “We continue to see babies being hospitalized from COVID-19 infections.”
The study was published in February in Frontiers in Nutrition, and the study was funded by the Gerber Foundation and the Children’s Miracle Network.
The study looked at how breast milk antibody protection changed when a mother received their first COVID-19 booster shot, said Joseph Larkin, UF/IFAS associate professor of microbiology and cell science and part of UF’s Emerging Pathogens Institute. Researchers looked at the antibody response and antibody functionality in breast milk and tested to see if antibodies were present after the babies drank breast milk with COVID-19 antibodies.
Larkin said this study suggests that breastfeeding can provide COVID-19 antibodies for infants too young to receive a vaccination – and that the antibodies wane in people’s bodies over time, so getting a booster can provide prolonged protection to babies that drink breast milk.
“When babies are born, they have an immature immune system, so they rely heavily on mom’s immune system,” he said. “Breastfeeding can serve as a gap in between while babies are building their own immune system.”
Larkin said some antibodies are transferred to fetuses through the placenta, as well, but that initial protection also lessens over time.
In this study, 14 lactating mothers and their babies were followed from before they received their COVID-19 booster until after they received their booster shots, Larkin said. Researchers tested the mothers’ blood to confirm their bodies made COVID-19 antibodies after a booster shot, tested breast milk to confirm the milk had antibodies in it and tested babies’ poop to confirm antibodies were present in the babies’ bodies.
To see if the breast milk’s antibodies worked against COVID-19, breast milk was placed in a 96-well plate with a lab-safe COVID virus strain, and researchers found these antibodies from the mother disable the virus, said Lauren Stafford, a UF/IFAS graduate research assistant and Ph.D. candidate in microbiology and cell science.
The study was a collaboration between UF/IFAS and the UF College of Medicine and included Dr. Josef Neu, professor of pediatrics within the division of neonatology at the UF College of Medicine.
“This shows how important breast milk and breastfeeding is for infant health during a pandemic,” Valcarce said.
END
Breastfeeding after COVID-19 booster can give babies antibodies
2024-03-04
ELSE PRESS RELEASES FROM THIS DATE:
Researchers closing in on genetic treatments for hereditary lung disease, vision loss
2024-03-04
PORTLAND, Ore. – Researchers who work with tiny drug carriers known as lipid nanoparticles have developed a new type of material capable of reaching the lungs and the eyes, an important step toward genetic therapy for hereditary conditions like cystic fibrosis and inherited vision loss.
Findings of the study led by Gaurav Sahay and Yulia Eygeris of the Oregon State University College of Pharmacy and Renee Ryals of Oregon Health & Science University were published today in the Proceedings of the National Academy of Sciences.
Unlike other types of lipid nanoparticles that tend to accumulate in the liver, the ones in this study, ...
COVID-19 associated with increased risk for autoimmune inflammatory rheumatic diseases up to a year after infection
2024-03-04
Below please find summaries of new articles that will be published in the next issue of Annals of Internal Medicine. The summaries are not intended to substitute for the full articles as a source of information. This information is under strict embargo and by taking it into possession, media representatives are committing to the terms of the embargo not only on their own behalf, but also on behalf of the organization they represent.
----------------------------
1. COVID-19 associated with increased risk for autoimmune inflammatory rheumatic diseases up to a year after infection
Vaccination showed some protection against AIRDs, depending on severity ...
UC Irvine receives $15 million NSF grant for integrative movement research
2024-03-04
Irvine, Calif. March 4, 2024 — The National Science Foundation has granted $15 million to the Integrative Movement Sciences Institute at the University of California, Irvine. This six-year funding, part of the NSF’s Biology Integration Institutes program, will support groundbreaking research led by Monica Daley, professor of ecology & evolutionary biology at the UCI School of Biological Sciences.
The research funded by this grant aims to understand the intricate mechanics of muscle control during rapid, unsteady movements in complex environments. Muscle ...
University of Houston engineer Metin Akay featured in study highlighting 50 scientists' contributions to biomedical engineering advancements
2024-03-04
Metin Akay, founding chair of the Biomedical Engineering Department at the University of Houston and John S. Dunn Professor, is one of 50 top scientists from 34 elite universities to publish a roadmap for groundbreaking research to transform the landscape of medicine in the coming decade.
Published on behalf of the Institute of Electrical and Electronics Engineers (IEEE), the world’s largest technical professional organization dedicated to advancing technology for humanity and the IEEE Engineering in Medicine and Biology Society (IEEE EMBS), the paper focus ...
JWST captures the end of planet formation
2024-03-04
March 4, 2024, Mountain View, CA – The James Webb Space Telescope (JWST) is helping scientists uncover how planets form by advancing understanding of their birthplaces and the circumstellar disks surrounding young stars, in a paper published in the Astronomical Journal, a team of scientists led by Naman Bajaj of the University of Arizona and including Dr. Uma Gorti at the SETI Institute, image for the first time, winds from an old planet-forming disk (still very young relative to the Sun) which is actively dispersing its gas ...
Good news—MS drugs taken while breastfeeding may not affect child development
2024-03-04
EMBARGOED FOR RELEASE UNTIL 4 P.M. ET, MONDAY, MARCH 4, 2024
MINNEAPOLIS – Certain medications for multiple sclerosis (MS) called monoclonal antibodies, taken while breastfeeding, may not affect the development of a child during the first three years of life, according to a preliminary study released today, March 4, 2024. The study will be presented at the American Academy of Neurology’s 76th Annual Meeting taking place April 13–18, 2024, in person in Denver and online. The study examined four monoclonal antibodies for MS: natalizumab, ocrelizumab, rituximab and ofatumumab.
MS is a disease in which the body’s immune system attacks ...
Programs intended to reduce health insurance premiums may make coverage less affordable for the middle class
2024-03-04
PITTSBURGH, March 4, 2024 — Reinsurance programs, which were created to help lower premiums and increase enrollment in the Affordable Care Act’s health insurance marketplaces, may have had the opposite effects for many potential marketplace enrollees, according to a study by health policy researchers at the University of Pittsburgh School of Public Health, Duke University and University of Minnesota.
The study, published today in Health Affairs, is the first to examine the effects of a post-American Rescue Plan Act ...
PrEP discontinuation in a US national cohort of sexual and gender minority populations, 2017–22
2024-03-04
In the U.S., sexual and gender minority populations are disproportionately affected by HIV. Pre-exposure prophylaxis (PrEP) is a key prevention method, but its effectiveness relies on consistent usage. While a significant body of research has addressed PreP initiation and adherence, far less attention has been paid to the reasons for and consequences of PrEP discontinuation.
A team of investigators conducted a four-year U.S. national cohort study exploring PrEP discontinuation among sexual and gender minority people who initiated PrEP. “Our cohort was entirely comprised of individuals ...
USC Study: Medicare Part D plans increased restrictions on drug coverage
2024-03-04
Medicare Part D plans significantly increased restrictions on prescription drugs, excluding more compounds from coverage or subjecting more of them to review before patients could access the treatments, according to a new study from USC researchers.
Among drugs not in Medicare “protected classes,” the share of drug compounds restricted or excluded by Part D plans surged from an average of 31.9% in 2011 to 44.4% in 2020, according to the study published in the March 2024 issue of Health Affairs. Brand-name-only compounds (those without a generic alternative) were especially limited, with more ...
Sacituzumab govitecan plus platinum-based chemotherapy in breast, bladder, and lung carcinomas
2024-03-04
“[...] these results support the rationale and potential for favorable clinical outcomes of combining SG therapy with platinum-based chemotherapeutics in solid tumors.”
BUFFALO, NY- March 4, 2024 – A new research paper was published in Oncotarget's Volume 15 on February 22, 2024, entitled, “Sacituzumab govitecan plus platinum-based chemotherapy mediates significant antitumor effects in triple-negative breast, urinary bladder, and small-cell lung carcinomas.”
Sacituzumab govitecan (SG) is an antibody-drug conjugate composed of an anti-Trop-2-directed antibody ...